• CA-074 Me: Precision Cathepsin B Inhibition for Lysosomal As

  2026-07-28

  CA-074 Me from APExBIO stands out as a highly selective, cell-permeable cathepsin B inhibitor, enabling advanced exploration of lysosomal pathways and regulated cell death in both in vitro and in vivo models. This article translates cutting-edge mechanistic findings into actionable protocols and troubleshooting strategies, empowering researchers to achieve reproducible, high-fidelity data in apoptosis, necroptosis, and inflammation research.

• LY-411575: Mechanistic Depth and Assay Implications in Gamma

  2026-07-28

  Explore the advanced mechanistic understanding of LY-411575, a potent gamma-secretase inhibitor, and learn how new insights inform assay design for Alzheimer's and cancer research. This article uniquely bridges the gap between molecular selectivity and practical research workflows.

• Annexin V-Cy5 Apoptosis Kit: Resolving Microglial Fate in Ly

  2026-07-27

  Explore how the Annexin V-Cy5 Apoptosis Kit enables precise, rapid apoptosis detection in microglia models of lysosomal stress. This deep dive connects advanced assay workflows with emerging neuroimmune research, offering unique insights beyond standard protocols.

• Dorsomorphin 2HCl: Precision AMPK Inhibition in Metabolic As

  2026-07-27

  Explore the pivotal role of Dorsomorphin 2HCl as a selective AMPK inhibitor in advanced metabolic research. This article delivers unique insight into its mechanistic applications, protocol considerations, and new findings on gut-liver axis modulation, setting it apart from existing content.

• Bifendate (DDB) in Hepatoprotection: Protocols and Optimizat

  2026-07-26

  Bifendate (DDB) delivers precise hepatoprotection by inhibiting autophagy and regulating lipid metabolism, setting a new benchmark for both in vitro and in vivo liver research. This article details actionable workflows, troubleshooting insights, and experimental enhancements that maximize DDB’s impact, with emphasis on APExBIO’s high-purity formulation.

• Chronic ONX-0914 Modulates Synaptic Plasticity in Mouse Hipp

  2026-07-25

  This study investigates how chronic immunoproteasome inhibition by ONX-0914 (PR-957) selectively alters long-term potentiation (LTP) and gene expression related to glutamatergic signaling in the murine hippocampus. The findings reveal specific roles for non-constitutive proteasomes in synaptic plasticity, with implications for both neuroscience research and immune modulation strategies.

• Translating Mechanism to Medicine with an FDA-Approved Libra

  2026-07-24

  Strategic insights for translational researchers on leveraging the DiscoveryProbe™ FDA-approved Drug Library (SKU: L1021) for drug repositioning and target discovery, with an in-depth exploration of recent mechanistic breakthroughs and workflow recommendations.

• Ginsenoside Rg1: Guiding Neuroimmune Assay Design with Treg

  2026-07-24

  Explore how Ginsenoside Rg1, a triterpene saponin, is redefining neuroimmune assay design through its Treg-dependent mechanism. This article delivers a unique, evidence-driven blueprint for optimizing neuroprotection workflows using Ginsenoside Rg1.

• Bispecific Anti-M1R/B6R Antibodies Enhance Orthopoxvirus Def

  2026-07-23

  This study systematically characterizes monoclonal antibodies targeting the M1R and B6R proteins of mpox virus and demonstrates that bispecific antibody formats—especially those with VH-CH1 domain switching—significantly improve antiviral efficacy in vitro and in vivo. These findings provide a detailed functional and epitope map and inform the rational design of broad-spectrum therapies against orthopoxviruses.

• PNU 74654: Applied Wnt Signaling Pathway Inhibitor Workflows

  2026-07-23

  PNU 74654 empowers researchers to dissect canonical Wnt/β-catenin signaling with exceptional precision, enabling advanced applications in cancer and stem cell research. This article delivers actionable workflows, protocol enhancements, and troubleshooting insights to help realize the full potential of this high-purity pathway inhibitor.

• Phenothiazines Enhance Macrophage Antibacterial Defense via

  2026-07-22

  The reference study reveals that phenothiazines, including promethazine hydrochloride, boost the antibacterial activity of macrophages by promoting reactive oxygen species (ROS) formation and autophagy. This mechanism highlights a promising host-directed approach to address intracellular bacterial infections and antibiotic resistance.

• Corynoline Induces Mitochondrial Apoptosis in Osteosarcoma v

  2026-07-22

  This study reveals that corynoline suppresses osteosarcoma cell growth by inducing G2/M cell cycle arrest and mitochondrial apoptosis through activation of the Src/JNK signaling pathway. The findings provide mechanistic insight that may inform therapeutic strategies and optimize cell death analysis in preclinical research.

• 28S rRNA Expansion Segments Architect Multilayered Nucleoli

  2026-07-21

  Wei et al. elucidate how multivalent expansion segments within 28S rRNA are critical for assembling the multilayered structure of the eukaryotic nucleolus. Their findings reveal that these RNA modules serve as architectural elements, and transferring them between species can reconstitute nucleolar layering in vitro—providing new mechanistic insight into nucleolar complexity.

• Exosomal SNORD52 Drives M2 Macrophage Polarization via JAK2/

  2026-07-21

  A recent study reveals that exosomal SNORD52 from hepatoma cells promotes M2 macrophage polarization by activating the JAK2/STAT6 pathway. This mechanism highlights a novel exosome-mediated axis in hepatocellular carcinoma progression, offering new targets for immune modulation in cancer research.

• Pexmetinib (ARRY-614) in Cytokine Inhibition: Workflows & In

  2026-07-20

  Pexmetinib (ARRY-614) stands out for its dual inhibition of p38 MAPK and Tie2, enabling precise modulation of inflammatory pathways in both in vitro and translational models. This guide translates recent structural and mechanistic advances into actionable protocols and troubleshooting strategies for researchers tackling cytokine synthesis and myelodysplastic syndromes.

15752 records 1/1051 page Next 12345 下5页 Last page